Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Wendy van de Sande

Erasmus University Rotterdam

Netherlands

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Microbiology

100%

Pharmacology

50%

Antifungal Therapy

80%

Fungal Pathology

50%

Antifungal Resistance

50%

Infectious Disease

40%

Antibiotic Resistance

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

MycetOS

Open Date: 2022-10-01

Close Date: 2023-12-01

Grant: Close

Point of care diagnostic test for mycetoma

Open Date: 2022-01-01

Close Date: 2025-12-01

Grant: Close

MycEXomics

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Study the efficacy of fosravuconazole as a potential new, safe, and affordable treatment for patients with eumycetoma

Open Date: 2015-01-01

Close Date: 2022-01-01

Articles30

Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella

Article Link

Year:

2025

Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin

Article Link

Year:

2025

Antiparasitic and Antifungal Activities of Cetyl-Maritima, a New N-Cetyl-Modified Maritima Derivative

Article Link

Year:

2025

A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma

Article Link

Year:

2025

Kinome analysis of Madurella mycetomatis identified kinases in the cell wall integrity pathway as novel potential therapeutic drug targets in eumycetoma caused by Madurella mycetomatis

Article Link

Year:

2025

Madurella tropicana and Madurella pseudomycetomatis identified as new causative agents of black grain eumycetoma in Senegal

Article Link

Year:

2025

Eumycetoma

Article Link

Year:

2025

Ibrexafungerp prolongs survival and reduces the eumycetoma grain size in Galleria mellonella infection models of two different causative agents of eumycetoma

Article Link

Year:

2025

The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma

Article Link

Year:

2025

Development of the Mycetoma Activity and Severity clinical Scale (MASS)

Article Link

Year:

2025

WHO global research priorities for antimicrobial resistance in human health

Article Link

Year:

2024

WHO global research priorities for antimicrobial resistance in human health

Article Link

Year:

2024

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan

Article Link

Year:

2024

Emerging Therapeutics

Article Link

Year:

2024

In Vitro and In Vivo Wide-Spectrum Dual Antimycetomal Activity of Eight Essential Oils Coupled with Chemical Composition and Metabolomic Profiling

Article Link

Year:

2024

Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives

Article Link

Year:

2024

Eumycetoma causative agents

Article Link

Year:

2024

Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against <i>Madurella mycetomatis</i>

Article Link

Year:

2024

The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis.

Article Link

Year:

2024

An updated list of eumycetoma causative agents and their differences in grain formation and treatment response.

Article Link

Year:

2024

A Falciformispora senegalensis grain model in Galleria mellonella larvae.

Article Link

Year:

2023

The First Case of <i>Fusarium falciforme</i> Eumycetoma in Sudan and an Extensive Literature Review about Treatment Worldwide

Article Link

Year:

2023

An update on the development of novel antifungal agents for eumycetoma

Article Link

Year:

2023

Antifungal Activity of Natural Naphthoquinones and Anthraquinones Against Madurella mycetomatis.

Article Link

Year:

2023

Evaluation of the antiparasitic and antifungal activities of new synthetic piperlongumine-type cinnamide derivatives: booster effect by halogen substituents.

Article Link

Year:

2023

Using a Madurella mycetomatis specific PCR on grains obtained via non-invasive Fine Needle Aspirated material is more accurate than cytology.

Article Link

Year:

2023

Comparing the performance of the common used eumycetoma diagnostic tests.

Article Link

Year:

2022

Diagnostics to support mycetoma management-Development of two target product profiles.

Article Link

Year:

2022

Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma

Article Link

Year:

2022

Staphylococcus aureus causing primary foot Botryomycosis mimicking actinomycetoma: a case report from Sudan.

Article Link

Year:

2022

Collaborators14

Israel Cruz

Head International Health Department

Instituto de Salud Carlos III

SPAIN

Paul Turner

University of Oxford

UNITED KINGDOM

Geraint Davies

Professor of Infection Pharmacology

University of Liverpool

UNITED KINGDOM

Tanya Applegate

Senior Lecturer

University of New South Wales

AUSTRALIA

Bernhard Biersack

GERMANY

H Rogier van Doorn

University of Oxford

UNITED KINGDOM

Kate Baker

University of Cambridge

UNITED KINGDOM

Yasushi Okazaki

Professor, Director

Juntendo University

JAPAN

Imad Abugessaisa

Professor

Osaka University

JAPAN

Mark Nicol

University of Western Australia

AUSTRALIA

David Chandler

UNITED KINGDOM

Phoebe CM Williams

The University of Sydney School of Public Health

AUSTRALIA

Emmanuel Edwar Siddig

NETHERLANDS

Prasad Dandawate

University of Kansas Medical Center

UNITED STATES

How do I reach out?

Meet Kite AI